What makes retatrutide different from other weight-loss drugs is that it is a 'triple agonist,' meaning it targets three hormones (GLP-1, GIP, and glucagon) that reduce your appetite, increase calorie burning, and help control your blood sugar
The only negative side effects the inoculated group reported were temporary injection site irritation and some mild fatigue
PT-141 is not approved by the MHRA for any therapeutic indication in the UK
They work by mimicking a hormone your body already produces naturally: GLP-1 (glucagon-like peptide-1)
Notably, systematic reviews in Western populations have revealed a significant association between increased cannabis use and AP incidence
Chen L, Chen X, Ruan B, Yang H, Yu Y